| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 73.18B | 29.48B | 31.79B | 31.15B | 30.91B |
| Gross Profit | 32.38B | 29.56B | 31.79B | 31.15B | 30.91B |
| EBITDA | 12.11B | 10.56B | 0.00 | 14.20B | 14.00B |
| Net Income | 7.79B | 7.76B | 7.41B | 9.92B | 9.62B |
Balance Sheet | |||||
| Total Assets | 1.46T | 1.41T | 1.41T | 1.35T | 1.18T |
| Cash, Cash Equivalents and Short-Term Investments | 108.10B | 108.17B | 140.83B | 119.31B | 120.05B |
| Total Debt | 236.69B | 300.67B | 313.81B | 310.86B | 245.66B |
| Total Liabilities | 1.37T | 1.33T | 1.33T | 1.27T | 1.11T |
| Stockholders Equity | 86.87B | 82.37B | 76.93B | 73.22B | 70.80B |
Cash Flow | |||||
| Free Cash Flow | 10.14B | 15.16B | 31.28B | 16.37B | -13.27B |
| Operating Cash Flow | 10.49B | 15.65B | 11.47B | 16.94B | -12.81B |
| Investing Cash Flow | -19.00B | -7.45B | -30.04B | -11.29B | 14.70B |
| Financing Cash Flow | 9.18B | -8.84B | 16.71B | -4.58B | -2.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $123.31B | 17.09 | 9.19% | 4.32% | -3.65% | -1.73% | |
76 Outperform | C$68.28B | 17.19 | 13.53% | 2.64% | 7.50% | -5.28% | |
74 Outperform | C$116.53B | 14.59 | 13.69% | 3.07% | -3.13% | 18.22% | |
74 Outperform | $220.87B | 11.30 | 16.78% | 3.34% | 3.07% | 144.41% | |
73 Outperform | C$329.68B | 16.70 | 15.28% | 2.58% | 2.13% | 25.16% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | C$130.22B | 16.03 | 10.10% | 3.61% | -1.30% | 20.41% |
Scotiabank reported a net income of $7,758 million for fiscal year 2025, slightly down from $7,892 million in 2024, with a diluted EPS of $5.67. However, the fourth quarter showed a significant improvement with a net income of $2,206 million, up from $1,689 million in the same period last year, and a diluted EPS of $1.65. The bank’s adjusted net income for the year was $9,510 million, indicating strong performance across its business lines, particularly in Global Wealth Management and Global Banking and Markets. The bank’s strategic restructuring and focus on strengthening its balance sheet and improving its loan-to-deposit ratio contributed to these results.
The most recent analyst rating on (TSE:BNS) stock is a Buy with a C$106.00 price target. To see the full list of analyst forecasts on Bank Of Nova Scotia stock, see the TSE:BNS Stock Forecast page.
Scotiabank has announced a dividend of $1.10 per share on its outstanding common shares, payable on January 28, 2026, to shareholders recorded by January 6, 2026. The bank continues to allow shareholders to receive dividends in the form of common shares through its Shareholder Dividend and Share Purchase Plan, with purchases made on the open market instead of issuing new shares from treasury. This decision reflects Scotiabank’s ongoing strategy to manage its share distribution and market presence effectively.
The most recent analyst rating on (TSE:BNS) stock is a Buy with a C$106.00 price target. To see the full list of analyst forecasts on Bank Of Nova Scotia stock, see the TSE:BNS Stock Forecast page.
Scotiabank has completed the transfer of its banking operations in Colombia, Costa Rica, and Panama to Davivienda, resulting in a new entity, Davivienda Group, where Scotiabank holds a 20% stake. This strategic move is expected to enhance Scotiabank’s international banking strategy by leveraging Davivienda’s regional expertise and Scotiabank’s global capabilities, aiming to improve profitability and expand their client base. The transaction is anticipated to result in a CAD $300 million after-tax loss in Q1 2026 due to foreign currency translation losses, but will also benefit Scotiabank’s CET1 ratio by reducing risk-weighted assets.
The most recent analyst rating on (TSE:BNS) stock is a Buy with a C$106.00 price target. To see the full list of analyst forecasts on Bank Of Nova Scotia stock, see the TSE:BNS Stock Forecast page.